Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 228,397,760 papers from all fields of science
Search
Sign In
Create Free Account
recombinant soluble CD4
Known as:
sT4 (recombinant)
, sT4
, soluble T4
Expand
A recombinant form of CD4 antigen with anti-HIV application. Recombinant soluble T4 antigen (rsT4) is derived from cell surface antigen CD4 lacking…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Broader (3)
Anti-HIV Agents
CD4 Antigens
Recombinant Proteins
Narrower (1)
recombinant soluble human CD4 protein
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
Characterization of the noncovalent complex of human immunodeficiency virus glycoprotein 120 with its cellular receptor CD4 by matrix-assisted laser desorption/ionization mass spectrometry.
C. Borchers
,
K. Tomer
Biochemistry
1999
Corpus ID: 23419173
The initial event in infection by the human immunodeficiency virus type 1 (HIV-1) is the interaction of the viral envelope…
Expand
Highly Cited
1996
Highly Cited
1996
Binding of HIV-1 virions or gp120-anti-gp120 immune complexes to HIV-1-infected quiescent peripheral blood mononuclear cells reveals latent infection.
Laurence Briant
,
N. Coudronnière
,
V. Robert-Hebmann
,
M. Benkirane
,
Christian Devaux
Journal of Immunology
1996
Corpus ID: 20456432
HIV-1-infected quiescent CD4+ cells harbor the virus in an inactive state until subsequent activation. The possibility that HIV-1…
Expand
1994
1994
The effects of high-dose recombinant soluble CD4 on human immunodeficiency virus type 1 viremia.
T. Schacker
,
R. Coombs
,
+6 authors
L. Corey
Journal of Infectious Diseases
1994
Corpus ID: 33601040
In vitro, low-passage clinical human immunodeficiency virus type 1 (HIV-1) isolates require up to 1000 times greater serum levels…
Expand
Highly Cited
1993
Highly Cited
1993
Resistance of a human serum-selected human immunodeficiency virus type 1 escape mutant to neutralization by CD4 binding site monoclonal antibodies is conferred by a single amino acid change in gp120
J. Mckeating
,
Jethro Bennett
,
+4 authors
P. Balfe
Journal of Virology
1993
Corpus ID: 1098789
We have selected an HXB2 variant which can replicate in the presence of a neutralizing human serum. Sequencing of the gp120…
Expand
1992
1992
Conjugation of soluble CD4 without loss of biological activity via a novel carbohydrate-directed cross-linking reagent.
S. Chamow
,
T. Kogan
,
D. Peers
,
R. Hastings
,
R. Byrn
,
A. Ashkenazi
Journal of Biological Chemistry
1992
Corpus ID: 25517813
Highly Cited
1991
Highly Cited
1991
Blocking of human immunodeficiency virus infection depends on cell density and viral stock age
S. Layne
,
M. Merges
,
J. Spouge
,
M. Dembo
,
P. Nara
Journal of Virology
1991
Corpus ID: 38289377
Quantitative infectivity assays were used to study how the blocking activity of soluble CD4 (sCD4) is affected by sCD4…
Expand
Highly Cited
1990
Highly Cited
1990
Characterization of recombinant gp120 and gp160 from HIV-1: binding to monoclonal antibodies and soluble CD4.
John P. Moore
,
J. McKeating
,
+4 authors
R. Weiss
AIDS (London)
1990
Corpus ID: 12069297
We compared four preparations of recombinant HIV-1 envelope glycoprotein: mammalian (Chinese hamster ovary cells) gp120 (Celltech…
Expand
1990
1990
CD4 immunoadhesin, but not recombinant soluble CD4, blocks syncytium formation by human immunodeficiency virus type 2-infected lymphoid cells
I. Sekigawa
,
S. Chamow
,
J. Groopman
,
R. Byrn
Journal of Virology
1990
Corpus ID: 39717513
Recombinant soluble CD4 (rCD4) has been shown to be an effective inhibitor of human immunodeficiency virus type 1 (HIV-1) and HIV…
Expand
Highly Cited
1989
Highly Cited
1989
Effect of recombinant soluble CD4 in rhesus monkeys infected with simian immunodeficiency virus of macaques
Mamoru Watanabe
,
K. Reimann
,
Peter A. DeLong
,
Theresa Liu
,
R. Fisher
,
N. Letvin
Nature
1989
Corpus ID: 4365568
The CD4 molecule is a high-affinity cell-surface receptor for the human immunodeficiency virus (HIV-1)1 and a soluble truncated…
Expand
Highly Cited
1989
Highly Cited
1989
Synergistic inhibition of human immunodeficiency virus type 1 (HIV-1) replication in vitro by recombinant soluble CD4 and 3'-azido-3'-deoxythymidine.
Victoria A. Johnson
,
M. Barlow
,
+4 authors
Robert T. Schooley
Journal of Infectious Diseases
1989
Corpus ID: 41094259
A combination of antiviral therapies that target different sites in the human immunodeficiency virus type 1 (HIV-1) replicative…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE